HR 4392 · 115th Congress · Health

To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

Introduced 2017-11-14· Sponsored by Rep. McKinley, David B. [R-WV-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2017-11-17)

Plain Language Summary

[AI summary unavailable — showing source text] This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

16 Democrats4 Republicans
Rep. Thompson, Mike [D-CA-5]CA
Rep. Johnson, Bill [R-OH-6]OH
Rep. Kustoff, David [R-TN-8]TN
Rep. Courtney, Joe [D-CT-2]CT
Rep. Castor, Kathy [D-FL-14]FL
Rep. Velazquez, Nydia M. [D-NY-7]NY
Rep. Engel, Eliot L. [D-NY-16]NY
Rep. Bishop, Sanford D., Jr. [D-GA-2]GA
Rep. Lewis, John [D-GA-5]GA
Rep. Higgins, Brian [D-NY-26]NY
Rep. Sewell, Terri A. [D-AL-7]AL
Rep. Fleischmann, Charles J. "Chuck" [R-TN-3]TN
Rep. Matsui, Doris O. [D-CA-6]CA
Rep. Lieu, Ted [D-CA-33]CA
Rep. Eshoo, Anna G. [D-CA-18]CA
Rep. Kennedy, Joseph P., III [D-MA-4]MA
Rep. King, Peter T. [R-NY-2]NY
Rep. Moore, Gwen [D-WI-4]WI
Del. Norton, Eleanor Holmes [D-DC-At Large]DC
Rep. Kildee, Daniel T. [D-MI-5]MI